Abstract
Since its introduction in 1984 by Inoue et al,1 percutaneous mitral balloon valvuloplasty (PMV) has been used successfully as an alternative to open or closed surgical mitral commissurotomy in the treatment of patients with symptomatic rheumatic mitral stenosis.2-18 PMV produces good immediate hemodynamic outcome, low complication rate, and clinical improvement in the majority of patients with mitral stenosis.2-18 PMV provides sustained clinical and hemodynamic improvement in patients with rheumatic mitral stenosis. The immediate and long term results appear to be similar to those of surgical mitral commissurotomy.2-18Today, PMV is the preferred form of therapy for relief of mitral stenosis for a selected group of patients with symptomatic mitral stenosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.